Close Menu

NEW YORK (GenomeWeb) – China's BGI said this week that it has received a CLIA certificate of registration for its Hong Kong laboratory.

BGI said the certification will help it to expand its offering of clinical sequencing services for specific diseases, including cancer and Mendelian disorders. It will also be useful for genomics-based clinical trial testing as part of BGI's CRO pharma solutions, which support drug discovery and development for biopharmaceutical clients.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
20
Sponsored by
Qiagen

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar
21
Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
26
Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.